Skip to main content

Antigen-binding characteristics of AbCD71 and its inhibitory effect on PHA-induced lymphoproliferation

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Abstract

Aim: To investigate the anti-lymphoproliferative effect of the prepared recombinant chimeric human/murine anti-cluster of differentiation(CD) 71 monoclonal antibody (AbCD71), which is composed of mouse-derived, antigen-binding variable regions and human-derived constant regions. Methods: After plasmids construction and transfection, the expression of AbCD71 in the transfectoma supernatant was determined by the sandwich ELISA. Indirect immunofluorescence assay was used to measure the antigen-binding characteristic and the percent CD71-expressed peripheral blood mononuclear cells (PBMC). The antibodies were purified from the ascites via diethylaminoethyl(DEAE)-Sephadex A-50 chromatography and then identified by SDS-PAGE. At last, inhibitory effect of AbCD71 on PHA-induced PBMC proliferation was calculated by methyl thiazolyl tetrazolium (MTT) assay. Results: Constant domain of heavy chain(CH) and light chain(CL)of AbCD71 were in the human C family and human C family, respectively. AbCD71 could compete with its original murine mAb to bind with CD71-positive human leukemia cell line CEM cells. AbCD71 could inhibit the peripheral blood mono-nuclear cell proliferation induced by phytohemagglutinin(PHA) in vitro in a dose-dependent manner, especially at time-points 0 and 12 h after induction. There was no statistical difference when compared with original murine mAb. Conclusion: The AbCD71 is a promising immunosuppressant. Our approach to blocking CD71 with the chimeric human/murine mAb provides a novel strategy for prolonging allograft survival.

Keywords: AbCD71; chimeric human/murine antibody; lymphoproliferation; transplantation rejection

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1745-7254.2007.00623.x

Affiliations: 1: Department of Immunology and Pharmacology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 2: Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China 3: Department of Pathobiology and Physiology, Medicine and Life Science College of Jianghan University, Wuhan 430056, China

Publication date: 2007-10-01

  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more